You just read:

Pevion's Therapeutic Candida Vaccine Shows Robust Systemic and Mucosal Immunogenicity, While Epidemiological Survey Confirms Excellent Market Potential

News provided by

Pevion Biotech AG

Oct 11, 2011, 06:36 ET